1Nickoloff B J, Osborne BA, Miele L. Notch signaling as a therapeu- tic target in cancer: a new approach to the development of cell fate modifying agents[J]. Oneogene,2003,22(42) :6598-6608.
2Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? [ J ]. Nat Rev Cancer, 2003,39 ( 10 ) : 756- 767.
3Enlund F, Behboudi A, Andren Y,et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin~ tumors [ J ], Exp Cell Res, 2004, 292(1) : 21-28.
4Koch U, radtke F. Notch and cancer: a double - edged sword [J]. Cell Mol Life Sci,2007,64(21 ) :2746-2762.
5Gallahan D, Jhappan C, Robinson G,et al. Expression of a trun- cated Int3 gene in developing secretory mammary epithelium spe- cifically retards lobular differentiation resulting in tumorigenesis [ J ]. Cancer Res, 1996, 56 ( 8 ) : 1775-1785.
6Girard L, Jdicoeur P. A full-length Notchl allele is dispensable for transformation associatedith a provirally activated truncated Notchl allele in Moloney MuLV-infected MMTV ( D )/mye trans-genie mice [J]. Oneogene,1998,29;16(4) :517-522.
7Farnie G, Clarke RB, Spenee K, et al. Novel cell culture tech- nique for primary duetal carcinoma in situ : role of Notch and epi- dermal growth factor receptor signaling pathways[ J]. J Natl Cane- er Inst, 2007,99(8) :616-627.
8Reedijk M, Pitmaduwage D, Diekson BC, et al. JAG1 expression is associated with a basal phcnotypc and recurrence in lymph node- negative breast cancer [ J ]. Breast Cancer Res Treat, 2008,111 (10) :439-448.
9Diekson BC, Mulligan AM, Zhang H, et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer[J]. Mod Pathol, 2007,20(6) :685-693.
10Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer [ J ]. Cancer Res, 2006, 66 (3) :1517-525.
9Parr C,Watkins G,Jiang W G.The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer[J].Int J Mol Med,2004,14(5):779-786.
10Reedijk M,Odorcic S,Chang L,et al.High-level coexpression of JAG1 and notch1 is observed in human breast cancer and is associated with poor overall surviva[J].Cancer Res,2005,65(18):8530-8537.
2AI- Hajj M, Wicha MS, Benito- Hernandez A, et al. Prospective i- dentification of tumorigenic breast cancer cell [ J ]. Proc Natl Acad Sci USA ,2003,100(7 ) :3983 - 3988.
3Jiang Y ,Su B, Meng X ,et al. Effect of siRNA - mediated silencing of Bmi - 1 gene expression on HeLa ceils [ J ]. Cancer science, 2010,101(2) :379 -386.
4Liu ZG, Liu L, Xu LH, et al. Bmi - 1 induces radioresistance in MCF - 7 mammary carcinoma cells [ J ]. Oncology reports,2012,27 (4) :1116 -1122.
5Zisuh AV, Han TQ, Zhan SD. Expression of telomerase & its signifi- cance in the diagnosis of pancreatic cancer[ J]. Indian J Med Res, 2012,135( 1 ) :26 -30.
6Shay JW, Wright WE. Role of telomeres and telomerase in cancer [ J ]. Semin Cancer Bio1,2011,21 (6) :349 - 353.
7Wang J, Guo Y, Wang B, et al. Lymphatic microvessel density and vascular endothelial growth factor - C and - D as prognostic factors in breast cancer: a systematic re -view and meta -analysis of the literature[ J ]. Mol BiolRep ,2012,39 (12) : 11153 - 11165.
8Bazarovav, Vansluis M. p16 (INK4a) -mediated suppression of telomerase in normal and malignant human breast cells[ J ]. Aging Cell ,2010,9 ( 5 ) :736 - 746.
